arrow
Return

A functionalized cell membrane biomimetic nanoformulation based on layered double hydroxide for combined tumor chemotherapy and sonodynamic therapy

delete2024-01-01
delete0
PRE
AI
G
Gaoming Li
Y
Yunqi Guo
N
Ni Cheng
Z
Zhiqiang Wang
M
Mengsi Zhan
H
Huxiao Sun
G
Goeun Choi
J
Jin‐Ho Choy
史向阳 cover
史向阳 (Xiangyang Shi) *
M
Mingwu Shen *
DOI:10.1039/d4tb00813hdelete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
The development of nanoformulations with simple compositions that can exert targeted combination therapy still remains a great challenge in the area of precision cancer nanomedicine. Herein, we report the design of a multifunctional nanoplatform based on methotrexate (MTX)-loaded layered double hydroxide (LDH) coated with chlorin e6 (Ce6)-modified MCF-7 cell membranes (CMM) for combined chemo/sonodynamic therapy of breast cancer. LDH nanoparticles were in situ loaded with MTX via coprecipitation, and coated with CMM that were finally functionalized with phospholipid-modified Ce6. The created nanoformulation of LDH-MTX@CMM-Ce6 displays good colloidal stability under physiological conditions and can release MTX in a pH-dependent manner. We show that the formulation can homologously target breast cancer cells, and induce their significant apoptosis through arresting the cell cycle via cooperative MTX-based chemotherapy and ultrasound (US)-activated sonodynamic therapy. The assistance of US can not only trigger sonosensitizer Ce6 to produce reactive oxygen species, but also enhance the cellular uptake of LDH-MTX@CMM-Ce6 via an acoustic cavitation effect. Upon intravenous injection and US irradiation, LDH-MTX@CMM-Ce6 displays an admirable antitumor performance towards a xenografted breast tumor mouse model. Furthermore, the modification of Ce6 on the CMM endows the LDH-based nanoplatform with fluorescence imaging capability. The developed LDH-based nanoformulation here provides a general intelligent cancer nanomedicine platform with simple composition and homologous targeting specificity for combined chemo/sonodynamic therapy and fluorescence imaging of tumors. A sonosensitizer-functionalized cell membrane biomimetic nanoplatform based on layered double hydroxide loaded with methotrexate can be constructed for fluorescence imaging-guided combined tumor chemotherapy and sonodynamic therapy.
Keywords:
CANCER
NANOPARTICLES

Journal

Journal of Materials Chemistry B cover
Journal of Materials Chemistry B
IF:
5.7
Papers:
1.1W
Citations:
4.3W

Organization

D
Donghua University
Scholars:
2.0W
Papers: 1.4W
Citations: 2.9W
D
Dankook University
Scholars:
5.5K
Papers: 5.6K
Citations: 5.1K